Endo International plc operates as a specialized pharmaceutical firm, engaged in the production and global distribution of both proprietary (branded) and unbranded (generic) medications. Within its Branded Pharmaceuticals division, the company markets prescription products such as XIAFLEX, for Dupuytren's contracture in adults; SUPPRELLIN LA, targeting central precocious puberty in children; and NASCOBAL nasal spray, for vitamin B12 deficiency. Other significant branded offerings include AVEED for hypogonadism, QWO as an injectable solution for moderate to severe cellulite in adult women's buttocks, PERCOCET for moderate-to-moderately-severe pain, TESTOPEL as an implantable pellet for testosterone replacement therapy (TRT), EDEX for erectile dysfunction, and LIDODERM, a topical patch containing lidocaine for pain relief.